| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 03, 2025 |
Director
Trans History: 338
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 750 |
| Jan 03, 2025 |
Director
Trans History: 338
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 400 |
| Jan 03, 2025 |
Director
Trans History: 338
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 1,000 |
| Jan 02, 2025 |
Director
Trans History: 338
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 166 | -- | 27,828 |
| Jan 02, 2025 |
Director
Trans History: 338
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,958 | -- | 1,958 |
| Dec 31, 2024 |
Director
Trans History: 338
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,338 | $413.33 | 29,610 |
| Dec 31, 2024 |
Director
Trans History: 338
|
Director | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,948 | $708.19 | 27,662 |
| Dec 31, 2024 |
Director
Trans History: 338
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,338 | -- | -- |
| Dec 18, 2024 |
SVP Finance & CFO
Trans History: 331
|
SVP Finance & CFO | Form 4 | Other acquisition or disposition | -- | -- | 1,515 |
| Dec 18, 2024 |
SVP Finance & CFO
Trans History: 331
|
SVP Finance & CFO | Form 4 | Other acquisition or disposition | -- | -- | 1,897 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.